epsilonpa-44
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00869778)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Clostridium perfringensImmunity, active
Clostridium perfringens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- epsilonpa-44
- εpa-44
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02862106 | Phase 2 | Sep 1, 2010 | Jiachen Biotechnology Ltd., Peking University, People's Liberation Army of China |
| NCT00869778 | Phase 2 | Jun 1, 2009 | Jiachen Biotechnology Ltd., Peking University, People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiachen Biotechnology Ltd. | For profit | 2 | 2 | 1 | 2009 |
| Peking University | Academic/Hospital | 2 | 0 | 1 | 2009 |
| People's Liberation Army of China | Government | 2 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1